Bicara Therapeutics Inc. ... (BCAX)
NASDAQ: BCAX
· Real-Time Price · USD
11.66
0.25 (2.19%)
At close: Aug 15, 2025, 3:45 PM
Bicara Therapeutics Common Stock Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q1 2023 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Mar 31, 2023 |
Cash & Equivalents | 436.61M | 462.06M | 489.71M | 520.76M | 203.85M | 203.85M | 230.44M | n/a |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | 6.84M | 6.63M | 65.82M | 2.12M | 2.09M | 2.09M | 2.09M | -4.16M |
Receivables | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 7.79M | 8.69M | 12.82M | 756K | 2.22M | n/a | 633K | n/a |
Total Current Assets | 444.39M | 470.75M | 502.53M | 521.51M | 206.08M | 206.08M | 231.07M | 4.16M |
Property-Plant & Equipment | 2.35M | 688K | 845K | 544K | 619K | 619K | 815K | n/a |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 9.2M | 7.32M | 66.66M | 2.66M | 2.71M | 2.71M | 2.91M | -4.16M |
Total Assets | 453.59M | 478.08M | 510M | 524.17M | 208.78M | 208.78M | 233.98M | n/a |
Account Payables | 2.91M | 2.74M | 4.51M | 1.96M | 4.68M | 4.68M | 3.19M | n/a |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | 1.07M | 591K | 607K | 308K | 300K | n/a | 285K | n/a |
Other Current Liabilities | 11.08M | 1.08M | 2.48M | 1.5M | 817K | n/a | 1.46M | n/a |
Total Current Liabilities | 17.23M | 19.12M | 17.99M | 14.48M | 16.07M | 16.07M | 15.09M | n/a |
Long-Term Debt | 1.16M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | n/a | n/a | n/a | n/a | 367.28M | n/a | 367.29M | 17.28M |
Total Long-Term Liabilities | 1.16M | n/a | 131K | 137K | 367.49M | 217K | 367.67M | 17.28M |
Total Liabilities | 18.39M | 19.12M | 18.12M | 14.62M | 383.56M | 16.28M | 382.75M | 17.28M |
Total Debt | 2.24M | 591K | 738K | 445K | 517K | 517K | 657K | n/a |
Common Stock | 7K | 7K | 7K | 7K | 2K | 2K | 2K | n/a |
Retained Earnings | -285.25M | -257.86M | -221.02M | -200.06M | -182.58M | -182.58M | -153.02M | n/a |
Comprehensive Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -98.8M |
Shareholders Equity | 435.2M | 458.96M | 491.88M | 509.56M | -174.78M | 192.5M | -148.77M | -17.28M |
Total Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |